back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-08-04 14:25 Tx date 2020-07-31 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$1,200,000
+200,000 vol $6.00 each |
3,573,053 | |
| Filed 2020-08-04 14:23 Tx date 2019-08-27 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$3,408,986
+1,704,493 vol $2.00 each |
3,373,053 | |
| Filed 2020-08-04 13:57 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,652 vol |
1,668,560 | |
| Filed 2018-04-25 17:24 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,651 vol |
||
| Filed 2018-04-25 Tx date 2018-04-25 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-31,702,651 vol |
1,668,561 | |
| Filed 2018-02-09 Tx date 2018-01-09 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$6,250,000
+31,250,000 vol $0.20 each |
33,371,212 | |
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
3,181,818 | ||
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Special Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,121,212 | ||
| Filed 2016-01-18 Tx date 2016-01-14 |
$EPI
ESSA Pharma Inc. |
Clarus Lifesciences III, L.P.
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|